Sign up to save your podcasts
Or
Share Striatal dopamine D2 receptor binding of risperidone in schizophrenic patients as assessed by 123I-iodobenzamide SPECT: a comparative study with olanzapine
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Striatal dopamine D2 receptor binding of risperidone in schizophrenic patients as assessed by 123I-iodobenzamide SPECT: a comparative study with olanzapine
The aim of this investigation was to compare the degree of striatal dopamine-(D2) receptor blockade by two atypical antipsychotic drugs, risperidone and olanzapine. The percentage of D2 receptor occupancy during treatment was calculated by comparing the results of 123I-iodobenzamide SPECT with those from healthy control subjects. Twenty inpatients suffering from schizophrenia or schizoaffective psychosis according to DSM IV/ICD-10 criteria were treated with clinically recommended doses of risperidone and compared with 13 inpatients treated with up to 20 mg olanzapine. Neuroleptic dose and D2 receptor blockade correlated strongly for both risperidone (Pearson r = –0.86, p = 0.0001) and olanzapine (Pearson r = –0.77, p = 0.002). There was no significant difference between the D2 receptor occupancy of the two substances when given in the clinically recommended dose range (unpaired t-test, t= –0.112, p=0.911).
View all episodes
By Ludwig-Maximilians-Universität MünchenThe aim of this investigation was to compare the degree of striatal dopamine-(D2) receptor blockade by two atypical antipsychotic drugs, risperidone and olanzapine. The percentage of D2 receptor occupancy during treatment was calculated by comparing the results of 123I-iodobenzamide SPECT with those from healthy control subjects. Twenty inpatients suffering from schizophrenia or schizoaffective psychosis according to DSM IV/ICD-10 criteria were treated with clinically recommended doses of risperidone and compared with 13 inpatients treated with up to 20 mg olanzapine. Neuroleptic dose and D2 receptor blockade correlated strongly for both risperidone (Pearson r = –0.86, p = 0.0001) and olanzapine (Pearson r = –0.77, p = 0.002). There was no significant difference between the D2 receptor occupancy of the two substances when given in the clinically recommended dose range (unpaired t-test, t= –0.112, p=0.911).
More shows like Medizin - Open Access LMU - Teil 12/22
View all
Center for Advanced Studies (CAS) Research Focus Evolutionary Biology (LMU) - HD
0 Listeners
Hegel lectures by Robert Brandom, LMU Munich
7 Listeners
MCMP – Philosophy of Science
1 Listeners
MCMP – Mathematical Philosophy (Archive 2011/12)
6 Listeners
Sommerfeld Lecture Series (ASC)
0 Listeners
Sommerfeld Theory Colloquium (ASC)
2 Listeners
John Lennox - Hat die Wissenschaft Gott begraben?
4 Listeners
MCMP
2 Listeners
Theoretical Physics Schools (ASC)
2 Listeners
Epistemology and Philosophy of Science: Prof. Dr. Stephan Hartmann – HD
1 Listeners